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Summary.-Thromboplastic and fibrinolytic activities of 14 lines of cultured
human cancer cells were estimated by modified Astrup's methods. High tissue
thromboplastic activity was found in one line of urinary-bladder cancer, 2 lines of
gastric cancer and one line of lung cancer, but no activity was found in 6 lines of lung
cancer. High fibrinolytic activity was noted in one line of gastric cancer and 2 lines of
lung cancer, but no activity was seen in 6 lines of lung cancer and one line of gastric
cancer. No plasmin activity was found. The tumour cell lines could be classified
into 3 groups on the basis of the 2 activities. Cancer cell lines could also be classified
into 2 groups: with high or low release of thromboplastin into culture media.
Fibrinolytic activity was found in the culture media of all cell lines with high
fibrinolytic activity. Fibrinolytic activity, but not thromboplastic activity, seemed
to be influenced by the constituents of culture media. No definite correlation was
found between the 2 activities and the histological types of the parent tumours of
the cultured cells.
THROMBOPLASTIC and fibrinolytic activi-
ties of tumour cells themselves are
considered to be important factors in the
following events: first, thrombosis (Rohner
etat., 1966) and disseminated intravascular
coagulation syndrome (Peck & Reiquam,
1973) in cancer patients; second, local
growth of the tumour at the primary site
(Peterson, 1968); third, haematogenous
metastases in the form of lodgement and
extravasation of arrested tumour cells in
remote organs (Tanaka et al., 1977).
Since the reports by Unkeless et al.
(1973) and Ossowski et al. (1973), the
correlation between oncogenic transforma-
tion of cells and plasminogen activator
production in established cell lines has
been watched with keen interest. Such a
plasminogen activator secreted by cul-
tured human cancer cell lines has also been
investigated in terms of purification and
characterization of its true nature (Wu et
al., 1977).
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Thus, much information has now been
accumulated on the role of coagulation
and fibrinolysis systems of cancer cells in
the field of oncology. But the systematic
evaluation of thromboplastic and fibrino-
lytic activities of human cancer cells
themselves has not been made.
In the present study, we estimated
these activities of 14 lines ofhuman cancer
cells in vitro, from which thromboplastic
material and plasminogen activator origi-
nating from the stromal elements of the
tumour and/or from the blood are
excluded.
MATERIALS AND METHODS
Cancer cells.-The cancer cell lines used in
this experiment were composed of one line of
urinarybladdercancer (KU 1), onelineofrenal
pelvic cancer (KP 1), 3 lines ofgastric cancer
(MKN 1, MKN 28, MKN 45) and 9 lines of
lung cancer (QG 56, QG 90, PC 1, PC 5, PC 7,
PC 8, PC 9, PC 10, PC 12). KU 1 was estab-M. KINJO ET AL.
(a)
FIG. 1.-(a)HistologyofparentaltumourofQG 90, diagnosed assmall-cellanaplasticcarcinoma. x 170.
(b) Histology ofQG 90transplanted s.c. into nude mouse. Small hyperchromatic tumourcells similar
to those in (a) proliferate diffusely in the dermis. x 170.
FIG. 2. Histology of PC 10 transplanted s.c. FIG. 3. Histology of PC 12 transplanted s.c.
into nude mouse. Large tumour cells of into nude mouse. Squamous-cell carcinoma
squamous-cell carcinoma proliferate in the proliferates in the dermis. Pseudohorn cysts
dermisshowingwhorlpattern inpart. x 170. are seen in the upper left corner. x 170.
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TABLE I.-Histological type of original cancers of cultured cell lines
KUT 1
KP 1
MKN 1
MKN 28
MKN 45
QG 56
QG 90
PC 1
PC 5
PC 7
PC 8
PC 9
PC 10
PC 12
Urinary bladder
Renal pelvis
Stomach
Stomach
Stomach
Lung
Lung
Lung
Lung
Lung
Lung
Lung
Lung
Lung
lished at Keio University; MKN 1, MKN 28
and MKN 45 were at Niigata University;
PC 1, PC 5, PC 7, PC 8, PC 9, PC 10, PC 12
were at Tokyo Medical College; QG 56, QG 90
were at Kyushu Cancer Centre Hospital.
KP 1 was established at Kyushu University.
Nine (KU 1, MKN 1, MKN 28, MKN 45,
QG 56, PC 1, PC 5, PC 7, PC 8) of the 14 cell
lines were described as established cell lines
in the literature (Kuga et al., 1975; Yasumoto
et al., 1976; Hojo, 1976). The others were
proved for their tumorigenicity in inude mice,
Transitional carcinoma
Anaplastic carcinoma
Adenocarcinoma
Well differentiated adenocarcinoma
Medullary carcinoma
Squamous-cell carcinoma
Small-cell anaplastic carcinoma
Squamous-cell carcinoma
Small-cell anaplastic carcinoma
Poorly differentiated adenocarcinoma
Poorly differentiated adenocarcinoma
Squamous-cell carcinoma
Squamous-cell carcinoma
Papillary adenocarcinoma
histological identity between the parent
tumours and the transplanted tumours in
nude mice (Figs 1, 2 and 3) and progressive
growth in in vitro culture systems, although
they have not been published yet. All the cell
lines were cultivated more than 10 passages
before the experiment at the Department of
Pathology, Faculty of Medicine, Kyushu
University. Histological cell type of the
original tumours at operation was shown in
Table I. The cancer cells were cultivated in
RPMI 1640 medium (GIBCO) supplemented
THROMBOPLASTIC
ACTIVITY /
Suspended in 0 9 ml
physiological saline
Freeze and thawing
Sonication 30W, 10 sec
Culture of human cancer cells
Washed twice with PBS (-)*
Suspended in PBS (-) and
centrifuged, 1000 rev/min 10 m
Pellet of cancer cells
(100 mg wet weight)
Centrifuged, 2000 rev/min
10 min
Supernate
Plasma recalcification time
tin
FIBRINOLYTIC
ACTIVITY
Suspended in 3 ml of
2M KSCN
Freeze and thawing
Sonication 30 W, 10 sec and
vibration 60 min
Centrifuged, 2000 rev/min
10 min
Adjusted to pH 1 with
N HCI
Centrifuged, 2000 rev/min
10 min
Dissolve the precipitate
in 2M KSCN
Adjusted to pH 7 with
solid NaHCO3
Fibrin plate
FIc. 4.-Assay methods for thromboplastic and fibrinolytic activities of cultured human cancer cells.
*PBS without Ca++ or Mg++.
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TABLE II.-Correlation ofwet weight of the tumour cells to cell number and protein content
Wet weight Cell number
(mg) (x 105)
100 87.7 ± 1.2
100 159-9± 7-7
100 128-8± 4-2
100 92-0± 6-8
100 103-6± 5-6
100 1005-0± 32-8
100 103-8± 24-0
100 1102-5±247-7
100 80-8± 12-1
100 736-0± 44-9
100 1450-0± 88-0
100 164-6± 22-4
100 135-3± 11-0
100 446-5± 29-9
100 232-5± 46-1
Protein content
in saline in 2M KSCN
(mg/ml) (mg/ml)
1-63±0-14 0-69±0-05
2-70±0-17 6-58±0-72
2-23±0-28 3-24±0-56
2-11±0-20 1-08±0-05
1-10±0-14 4-20±1-55
3-25±0-28 1-60±0-08
0-95±0-10 1-92±0-20
4-97±0-20 3-10±0-12
6-22± 1-01 4-28±0-36
7-42±1-15 5-44±1-12
8 48±0-22 6-04±0-84
5-89±0-22 4-96±0-64
2-72±0-14 0-76±0-05
3-39±0-40 6-68±1-44
6-15±0-20 3-56±0-12
KU 12 and KP 1 were cultivated in Eagle's MEM+ 10% FCS and the others in
RPMI 1640+20% FCS. Cell number and protein content were demonstrated in
mean numbers ±s.d.
by 20% foetal calf serum (GIBCO) and in
Eagle's MEM (Nissui Pharmaceutical Co.,
Japan) supplemented by 10% foetal calf
serum (FCS). Urinary-bladder cancer (KU 1)
was cultivated in RPMI 1640 supplemented
by 20% FCS (KU 11) or Eagle's MEM supple-
mented by 10% FCS (KU 12). Phosphate-
buffered saline used for washing the cultured
cells was free ofCa++ orMg++. Other chemicals
were of the best analytical grade.
Assayfor the activities.-As shownin Fig. 4,
100 mg wet weight of cultured human cancer
cells were harvested from the culture bottles
and the cell number was counted. The lysates
of cancer cells for the assay were obtained by
the modified methods of Astrup (1965, 1970)
shown in Fig. 4. Sonication was performed
with sonifier, Model W185 E (Branson Sonic
Power Co., U.S.A.). The total protein concen-
tration of each lysate was determined by the
method of Lowry et al. (1951) and shown in
Table II.
Thromboplastic activity was assayed at
3700 in a system consisting of 0-2 ml of
0-03% CaCl2. The solutions were preheated for
3 min before the experiment. The activity was
recorded asplasma recalcificationtime (PRT).
In order to determine whether coagulation
mainly depended upon extrinsic or intrinsic
system, 3 groups were made. First, all the
lysates were subjected to an assay system
using standard human plasma; second, 9 cell
lines which showed high-to-moderate activity
in the first assay system were also assayed in
a system with Factor VII or Factor IX
deficient human plasma instead of standard
human plasma.
Specimens of human brain taken from 4
cadavers aged 64 to 74 years were also treated
as a control and used to assay the thrombo-
plastic activity using the same method as for
the cultured cells.
For the assay of fibrinolytic activity, 30 ,ul
aliquots obtained by the method in Fig. 4
wereapplied to thestandardandplasminogen-
free fibrin plates, which were then incubated
at 370C for 18 h. Fibrinolytic activity was
compared with standard urokinase (Mochida
Pharmaceutical Co., Japan) and expressed in
International Units (i.u./ml) of urokinase.
Furthermore, plasminogen-free fibrinogen
was prepared from human fibrinogen (The
Green Cross Corp., Japan) by affinity chroma-
tography on lysine-Sepharose (Daiichi Pure
Chemicals Co., Japan) by the method of
Deutsch & Mertz (1970).
Used and unused culture media were also
examined for thromboplastic and fibrinolytic
activities, using methods similar to those
shown in Fig. 4.
Correlation of wet weight of tumour cells to
cell number and protein content.-Thrombo-
plastic and fibrinolytic activities were ex-
pressed in terms of activity per 100mg wet
weight, according to Astrup's description.
Each cell line of 100 mg of wet weight showed
moderate variation in cell number and in
protein content, as shown in Table II.
Cell line
KU 11
KU 12
KP 1
MKN 1
MKN 28
MKN 45
QG 56
QG 90
PC 1
PC 5
PC 7
PC 8
PC 9
PC 10
PC 12
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RESULTS
Thromboplastic activity
Plasma recalcification time in seconds
(PRT) was recorded on 10 samples ofeach
tumour cell line. Average values and stan-
dard deviations are shown in Table III. A
varied degree of thromboplastic activity
was found. Some cell lines ofgastric cancer
and Urinary bladder cancer showed high
activity, whereas most of lung cancer cell
lines had low activity. In terms of throm-
boplastic activity, the cancer cell lines
used in this experiment could be divided
into 3 arbitrary groups, as shown in
Table VII. The urinary-bladder cancer
(KU 11 and KU 12), 2 gastric cancers
(MKN 1, MKN 28) and one lung cancer
(QG 56) belonged to the first group with
high thromboplastic activity(PRT <30).
The renal pelvis cancer (KP 1), 1
gastric cancer (MKN 45) and 2 lung
cancers (PC 8, PC 9) belonged to the
second group showing moderate activity
(PRT 30-60). The third group (PRT
>60) included 6 lung cancers (QG 90,
PC 1, PC 5, PC 7, PC 10, PC 12).
TABLE III.-Thromboplastic activity of
cultured human cancer cell lines
Plasma recalcification time
Mean see±s.d.)
Cell lines
KU 11
KU 12
KP 1
MKN 1
MKN 28
MKN 45
QG 56
QG 90
PC 1
PC 5
PC 7
PC 8
PC 9
PC 10
PC 12
Culture media
MEM
RPMI 1640
Cells
20-5± 1-4
23-4± 1-2
52-7± 9-0
19-5± 1-2
23-1± 2-2
483± 54
16-8± 06
274 9±25-6
104-7± 8-1
>300
70-7± 48
375± 35
49-7± 3-8
70-7± 8-2
111-3±10-0
Culture
medium
78-6±19-3
107-6± 14-3
105-2± 17-2
76-0± 12-2
242-4±38-8
279-8± 15-3
59-7± 5-9
>300
156-8± 10-0
>300
>300
141-2+ 6-3
83-7± 4-9
280-4±24-4
>300
>300
> 300
KU 12 and KP 1 were cultivated in Eagle's
MEM+ 10% FCS and the others were in RPMI
1640+20% FCS.
Nine tumour cell lines showing high and
moderate activity (PRT <60 s) were
then examined using human plasma defi-
cient in either Factor VII (extrinsic factor)
or Factor IX (intrinsic factor). Mean
values and standard deviations of PRT in
4 samples in each are shown in Table IV.
Every cell line showed high activity when
using Factor IX-deficient plasma but
lower activity in a system using Factor
VII-deficient plasma than with standard
human plasma. This result implies that the
thromboplastic activity of tumour cells is
due to their own tissue thromboplastin.
TABLE IV.-Tumour-cell-related thrombo-
plastic activity using plasma deficient in
either Factor VII (extrinsic factor) or
Factor IX (intrinsicfactor)
Plasma recalcification time (s) (Mean+s.d.)
VII-deficient IX-deficient
Cell line plasma plasma
KU 11 104-93± 409 19-60±1*10
KU 12 126-43±14-17 24-90±1-60
KP 1 120-50+ 0 50 43-10±0-70
MKN 1 124 70±11-38 25-25±0 75
MKN 28 165-63+ 6-28 30-80±1-20
MKN 45 256-60± 1-20 52-70±2-80
QG 56 153-10+ 3-43 22-45±0-10
PC 8 122-90± 0-20 40 70±0 50
PC 9 262-55± 3-15 38-40±0-80
KU 12 and KP 1 were cultivated in Eagle's
MEM+ 10% FCS andthe others in RPMI 1640+20%
FCS.
The mean values of thromboplastic
activity of human brain are shown in
Table V. These values resemble those of
KU 11, KU 12, MKN 1 and QG 56, belong-
ing to the first group.
Culture media from cell lines with high
thromboplastic activity (KU 11, KU 12,
MKN 1, QG 56) showed moderate to low
thromboplastic activity, as shown in
Table III, but the media from cell lines
with low thromboplastic activity showed
none. In onegastric cancer (MKN 28), how-
ever, the cells showed high activity, while
the culture medium had extremely low
activity. Fresh culture medium showed no
thromboplastic activity.
Urinary-bladder cancer (KU 1) showed
similarly high activity, whether cultivated
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TABLE V.-Thromboplastic activity of human brain
1 1/2 1/4 1/8 1/16 1/32 1/64 1/128
21-3 21-7 23-7 26-3 29-7 35-4 41-5 52-6
03 04 0-8 09 1-4 2-7 1-4 3-7
TABLE VI.-Fibrinolytic activity ofcultured
human cancer cell lines
Tissue plasminogen-activator activity
(i.u./ml of urokinase, mean ±s.d.)
Cell line
KU 1'
KU 12
KP 1
MKN 1
MKN 28
MKN 45
QG 56
QG 90
PC 1
PC 5
PC 7
PC 8
PC 9
PC 10
PC 12
Culture media
MEM
RPMI 1640
Cells
0-22±0-13
0
0-20+0 04
1-88±0*77
0-35±0-12
0
1-68±0-79
0-66±0-22
0
0
0
0
6-67±0-80
0
0
Culture media
0
0
0
0-29{0-14
0
0
0-51±0-10
0-47±0
0
0
0
0
0-74±0-14
0
0
0
0
KU 12 and KP 1 were cultivated in Eagle's
MEM+ 10% FCS andthe others inRPMI 1640+20%
FCS.
in RPMI 1640 supplemented by 20% FCS
(KU 11) or in Eagle's MEM supplemented
by 10% FCS (KU 12).
Fibrinolytic activity
Five samples of each cell line were
assayed on the standard fibrin plates for
plasminogen tissue activator activity.
Average values and standard deviations
expressed as urokinase International Units
(i.u./ml) are shown in Table VI.
Fibrinolytic activity was recognized in
7 lines (KU 11, KP 1, MKN 1, MKN 28,
QG 56, QG 90, PC 9) out of 14 (Table VI).
Cancer cell lines were divided into 3
arbitrary groups as shown in Table VII.
Gastric cancer (MKN 1) and 2 lines oflung
cancer (QG 56, PC 9) showed high fibrino-
lytic activity (>1 i.u./ml of urokinase).
Urinary bladder cancer (KU 11), renal
pelvic cancer (KP 1), one gastric cancer
(MKN 28) and one lung cancer (QG 90)
TABLE VII.-Thromboplastic and fibrino-
lytic activities of cultured human cancer
cell lines (a summary)
Thromboplastic activity (sec)
\~~~~~~~~~~A
h~ >1
.
£_ <1
e; E .*
. -I 0
d-
High
<30
MKN 1
QG 56
KU 11
MKN 28
KU 12
Intermediate
30-60
PC 9
KP 1
Low
>60
QG 90
MKN 45 PC I
PC8 PC5
PC 7
PC 10
PC 12
KU 12 and KP 1 were cultivated in Eagle's
MEM+10% FCS
showed moderate activity (<1 i.u./ml of
urokinase). Fibrinolytic activity could not
be detected in 6 lines oflung cancer (PC 1,
PC5, PC 7, PC 8, PC 10, PC 12) and one
line ofgastric cancer (MKN 45).
Urinary-bladder cancer cultured in
RPMI 1640 supplemented by 20% FCS
(KU 11) showed moderate activity, but
the cells cultivated in Eagle's MEM
supplemented by 10% FCS (KU 12)
showed none (Table VI).
Culture media from 3 lung cancer cul-
tures (QG 56, QG 90, PC 9) and gastric
cancer (MKN 1), whose cells showed
fibrinolytic activity, revealed slight
activity (Table VI), but unused culture
medium showed none.
No plasmin activity was found in any
cancer cell lines on plasminogen-free
plates.
DISCUSSION
It is well known that thromboplastin is
contained in fibroblasts (Zacharski &
McIntyre, 1973) amnion cells (Maynard
et al., 1976) leucocytes (Kochiba et al.,
1972), tumour cells of animals (Peterson
& Zettergren, 1970; Tanaka et al., 1977)
Dilution
PRT (sec)
s.d.
1/256
66-3
6-7
1/512
84-4
10-2
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and human tumour cells (Gasic et al.,
1976). We found that cultured human
cancer cells had varied thromboplastic
activity. From the results of coagulation
studies using standard, Factor VII-
deficient and Factor IX-deficient human
plasmas, the thromboplastic activityseems
to be due to tissue thromboplastin of the
tumour cells themselves. Thromboplastic
activity of the cancer cells seems to be
very important in terms of the patho-
physiology of the patients with malig-
nancy, such as thrombosis, non-bacterial
thrombotic endocarditis (Rohner et al.,
1966) and disseminated intravascular co-
agulation syndrome (Peck & Reiquam,
1973). This activity is also considered to
be closely related to fibrin deposition at
the advancing border of tumours (Tanaka
et al., 1977) and to the lodgement of circu-
lating tumour cells in remote organs by
tlhrombus formation (Kinjo, 1978).
Tumour cell lines were divided into 3
arbitrary groups on the basis of their
thromboplastic activity. Two lines of
gastric cancer, one line of lung cancer and
one line of urinary-bladder cancer were
included in the first group showing high
thromboplastic activity, while 6 lines of
lung cancer belonged to the third group
showing little or no activity. It is suggested
that the patients with cancer in the first
group are apt to give rise to a hyper-
coagulable state and lead to thrombosis or
the syndrome of disseminated intravascu-
lar coagulation.
Thromboplastic activity was found in
the culture medium from some tumour
cell lines of high activity. On the other
hand, culture medium from the cell line
of gastric cancer (MKN 1) with high
thromboplastic activity, showed extremely
low activity. These facts suggest that some
tumour cell lines are prone to release a
thromboplastic material into the medium.
No definite correlation was found between
thromboplastic activity and the histo-
logical features oforiginal tumours.
The cultured human cancer cells also
showed varied fibrinolytic activity. The
assay of this activity was based on the
modified Astrup's method, using standard
fibrin plates which were examined for
evidence ofplasminogen activator activity
(Astrup & Kok, 1970). Unkeless et al.
(1973) adopted the method using isotope-
labelled fibrin plates, and estimated the
plasminogen-activator activity from the
released radioactive material. Their
method seemed to be very sensitive for
evaluating plasminogen-activator activity.
The main reasons why the modified
Astrup's method was adopted were as
follows. (1) The data obtained with modi-
fied Astrup's method were broadly ac-
cepted. (2) Experiments could be done
with lower cost.
Rifkin et al. (1974) found elevated levels
of fibrinolysis independent ofplasminogen
and reported that this phenomenon was
due to another type ofprotease. Nagy et al.
(1977) also found a similar phenomenon
in cultured human cancer cells, and they
thought that there might be a plasminogen
activator in residual blood among the cells.
In the present study, we found no tumour
cell lines producing plasmin or plasmino-
gen independent protease.
According to this experiment, 2 lines of
squamous-cell carcinoma of the lung and
one of adenosquamous carcinoma of the
stomach showed high fibrinolytic activity.
Peterson et al. (1975) showed a compara-
tively high fibrinolytic activity in 40-50%
of bronchogenic carcinomas classified as
epidermoid carcinoma or adenocarcinoma,
but a comparatively low activity in most
small cell anaplastic carcinoma. It is note-
worthy to mention that their study did
not exclude the stromal elements, which
may have high fibrinolytic activity. Here,
we found that 2 lines of high fibrinolytic
activity were squamous cell carcinoma of
the lung, while 6 lines of low fibrinolytic
activity included 2 lines of anaplastic
carcinoma and 3 lines of adenocarcinoma
of the lung. No definite correlation was
found between fibrinolytic activity and the
histology ofthe original tumours.
In recent years the studies of Unkeless
et al. (1973) and Ossowski et al. (1973) have
been of particular interest. They have
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reported the appearance of plasminogen
activator in cell cultures associated with
oncogenic transformation, although Mott
et al. (1974) and Wolf & Goldberg (1976)
revealed lack of correlation in established
cell lines. Rosenthal et al. (1977) and Nagy
et al. (1977) showed that fibrinolytic
activity Qf cancer cells was very varied,
and that it was closely associated with the
passage history of the cultured cells. Our
present studyalso showsthatplasminogen-
activator production could be changed by
the constituents of culture media, while
thromboplastin production showed no
such correlation. Some publications have
appeared recently, describing an identity
of plasminogen activator of the cultured
human cancer cells with urokinase (Astedt
& Holmberg, 1976; Wu et al., 1977).
It is worth mentioning that plasminogen
activator was found in the culture medium
from tumour cells with high fibrinolytic
activity and not in the culture medium of
those with low fibrinolytic activity or
none. Such a fact suggests the release of
plasminogen activator from the tumour
cells, as described by Bjorlin et al. (1972).
This study was supported by a Grant-in-Aid for
Scientific Research from the Ministry of Education,
Science and Culture in Japan (No. 101560).
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